Compare · OMCL vs XNDU
OMCL vs XNDU
Side-by-side comparison of Omnicell Inc. (OMCL) and Xanadu Quantum Technologies Limited (XNDU): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OMCL and XNDU operate in Computer Manufacturing (Technology), so they compete in similar markets.
- XNDU is the larger of the two at $2.92B, about 1.9x OMCL ($1.55B).
- XNDU has been more active in the news (11 items in the past 4 weeks vs 6 for OMCL).
- OMCL has more recent analyst coverage (24 ratings vs 3 for XNDU).
- Company
- Omnicell Inc.
- Xanadu Quantum Technologies Limited
- Price
- -
- -
- Market cap
- $1.55B
- $2.92B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- News (4w)
- 6
- 11
- Recent ratings
- 24
- 3
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest OMCL
- TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
- Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
- EVP&CHIEF LEGAL/ADMIN OFFICER Manley Corey J covered exercise/tax liability with 4,025 shares, decreasing direct ownership by 4% to 108,985 units (SEC Form 4)
- VP, Chief Accounting Officer Nutt Brian H. covered exercise/tax liability with 937 shares, decreasing direct ownership by 4% to 22,266 units (SEC Form 4)
- President & COO Njoku Nnamdi covered exercise/tax liability with 3,670 shares and sold $113,609 worth of shares (3,083 units at $36.85) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 161,224 units (SEC Form 4)
- CHAIRMAN, CEO Lipps Randall A covered exercise/tax liability with 12,350 shares, decreasing direct ownership by 2% to 511,096 units (SEC Form 4)
- SEC Form 10-Q filed by Omnicell Inc.
- EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
- Omnicell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Omnicell Announces Second Quarter 2026 Financial Results
Latest XNDU
- Xanadu Charts Path to Over 1,000 Logical Qubits by 2031
- SEC Form 424B3 filed by Xanadu Quantum Technologies Limited
- SEC Form 424B3 filed by Xanadu Quantum Technologies Limited
- SEC Form 6-K filed by Xanadu Quantum Technologies Limited
- Government of Canada Invests CAD $195 Million in Xanadu to Build the Quantum Supply Chain
- Xanadu Secures CAD $195 Million and Establishes Landmark Advanced Photonics Facility
- UPDATE -- Canada-Japan Support Advances Xanadu and Mitsubishi Chemical Partnership on Quantum Semiconductor Research
- Canada-Japan Funding Fuels Xanadu and Mitsubishi Chemical Partnership on Quantum Semiconductor Research
- Xanadu Announces Technological Roadmap Presentation
- SEC Form 424B3 filed by Xanadu Quantum Technologies Limited